Matinas BioPharma director James Scibetta resigns from board effective Jan 21, 2025

Matinas BioPharma Holdings, Inc.

James S. Scibetta resigned from the Board of Directors effective January 21, 2025.
He also resigned from his positions on the Audit and Compensation Committees.
Resignation was due to other professional obligations, not a material disagreement.
No replacement director has been announced at this time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.